Format

Send to

Choose Destination
Autophagy. 2018;14(4):685-701. doi: 10.1080/15548627.2017.1407887. Epub 2018 Jan 29.

AKT-mediated phosphorylation of ATG4B impairs mitochondrial activity and enhances the Warburg effect in hepatocellular carcinoma cells.

Author information

1
a Department of Biochemistry and Molecular Biology , College of Basic Medical Sciences, Third Military Medical University , Chongqing, China.
2
b Battalion 17 of Students , College of Preventive Medicine, Third Military Medical University , Chongqing, China.
3
c Department of Gastroenterology , Xinqiao Hospital, Third Military Medical University , Chongqing , China.
4
d College of Educational Science, Chongqing Normal University , Chongqing , China.
5
e Department of Hepatobiliary Surgery , Xinqiao Hospital, Third Military Medical University , Chongqing , China.
6
f Center for Pharmacogenetics , Department of Pharmaceutical Sciences, School of Pharmacy , University of Pittsburgh , Pittsburgh , PA , USA.
7
g Department of Molecular Biosciences and Department of Radiation Oncology , University of Kansas Cancer Center, University of Kansas , Lawrence , KS , USA.
8
h Institute of Cancer, Xinqiao Hospital, Third Military Medical University , Chongqing , China.

Abstract

Phosphorylation is a major type of post-translational modification, which can influence the cellular physiological function. ATG4B, a key macroautophagy/autophagy-related protein, has a potential effect on the survival of tumor cells. However, the role of ATG4B phosphorylation in cancers is still unknown. In this study, we identified a novel phosphorylation site at Ser34 of ATG4B induced by AKT in HCC cells. The phosphorylation of ATG4B at Ser34 had little effect on autophagic flux, but promoted the Warburg effect including the increase of L-lactate production and glucose consumption, and the decrease of oxygen consumption in HCC cells. The Ser34 phosphorylation of ATG4B also contributed to the impairment of mitochondrial activity including the inhibition of F1Fo-ATP synthase activity and the elevation of mitochondrial ROS in HCC cells. Moreover, the phosphorylation of ATG4B at Ser34 enhanced its mitochondrial location and the subsequent colocalization with F1Fo-ATP synthase in HCC cells. Furthermore, recombinant human ATG4B protein suppressed the activity of F1Fo-ATP synthase in MgATP submitochondrial particles from patient-derived HCC tissues in vitro. In brief, our results demonstrate for the first time that the phosphorylation of ATG4B at Ser34 participates in the metabolic reprogramming of HCC cells via repressing mitochondrial function, which possibly results from the Ser34 phosphorylation-induced mitochondrial enrichment of ATG4B and the subsequent inhibition of F1Fo-ATP synthase activity. Our findings reveal a noncanonical working pattern of ATG4B under pathological conditions, which may provide a scientific basis for developing novel strategies for HCC treatment by targeting ATG4B and its Ser34 phosphorylation.

KEYWORDS:

AKT; ATG4B; F1Fo-ATP synthase; HCC; Warburg effect; phosphorylation

PMID:
29165041
PMCID:
PMC5959332
DOI:
10.1080/15548627.2017.1407887
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center